Eccentric Cycling Exercise During Pulmonary Rehabilitation in Patients With Cardiopulmonary Diseases

NCT ID: NCT07042750

Last Updated: 2025-06-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-02

Study Completion Date

2026-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Eccentric cycling exercise (ECC) allows training at low metabolic costs and may therefore be valuable for patients with pulmonary vascular disease (PVD). For these patients, regular exercise training has an evidence level 1A recommendation in the current guidelines. Exercise training during longer and regular periods provides chronic adaptation, for which ECC was recently found to have a greater effectiveness than CON by increasing muscle strength, hypertrophy, six-minute walking distance and furthermore, by increasing maximum oxygen uptake (V'O2max) especially in patients with chronic obstructive pulmonary disease (COPD), chronic left heart failure or coronary heart disease. Furthermore, we conducted an RCT in which we exposed patients with PVD to ECC and concluded that ECC is a feasible and well-tolerated exercise modality for PVD patients with severely lower O2 demand and load to the right ventricle. The study in patients with PVD was started (EccRehab), and the great potential was recognized. Therefore there was an indication to open the inclusion criteria to all cardiopulmonary patients with indication for pulmonary rehabilitation (EccRehab2).

For this purpose, the aim of this project is to investigate whether ECC improves exercise capacity and possibly hemodynamics during prolonged rehabilitation programs in patients with cardiopulmonary diseases.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Eccentric Exercise Training

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Intervention: Eccentric cycling (instead of usual cycling) + standard care Control: Standard care
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Eccentric cycling

Patients perform eccentric cycling exercise instead of normal cycling exercise in addition to standard car during a cardiopulmonary rehabilitation

Group Type EXPERIMENTAL

Eccentric cycling exercise

Intervention Type OTHER

Patients perform eccentric cycling exercise instead of normal cycling exercise in addition to standard car during a cardiopulmonary rehabilitation

Standard care

Patients perform cardiopulmonary rehabilitation according to standard care

Group Type ACTIVE_COMPARATOR

Standard Care Arm

Intervention Type OTHER

Patients perform cardiopulmonary rehabilitation according to standard care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Eccentric cycling exercise

Patients perform eccentric cycling exercise instead of normal cycling exercise in addition to standard car during a cardiopulmonary rehabilitation

Intervention Type OTHER

Standard Care Arm

Patients perform cardiopulmonary rehabilitation according to standard care

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with PVD, either PAH or CTEPH via right heart catheterization, according to recent guidelines \[9\]
* Diagnosed with a cardiopulmonary disease as indication for a pulmonary rehabilitation
* Stable medication for at least 1 month
* Age 18years to 85 years
* No resting hypoxemia (PaO2 \>7.3 kPa)
* Medical indication to prescibe a pulmonary rehabilitation

Exclusion Criteria

* Any co-morbidity that limits the patient to participate the full rehabilitation
* Enrollments in other trials with active treatments
* Language barriers that limits the patient to participate in the rehabilitation
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Klinik Barmelweid

OTHER

Sponsor Role collaborator

Silvia Ulrich Somaini

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Silvia Ulrich Somaini

Prof. Silvia Ulrich

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Klinik Barmelweid

Barmelweid, , Switzerland

Site Status RECRUITING

Universitätsspital Zürich

Zurich, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Silvia Ulrich, Prof. dr. med.

Role: CONTACT

+41442564362

Julian Müller, Dr. sc. med.

Role: CONTACT

0432539349

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Thomas Sigrist, Dr. med.

Role: primary

062 857 20 00

Silvia Ulrich, Prof. dr. med.

Role: primary

0432539349

Julian Müller, Dr. sc. med.

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EccRehab2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.